Skip to content
Not evaluated by SAHPRA · For information & research use only · Not intended to diagnose, treat, cure or prevent any disease · Consult a healthcare professional
This product has not been evaluated by SAHPRA. For information purposes only — not intended to diagnose, treat, cure or prevent any disease.
← Back to shop
PerformanceResearch vialIGF-1 analoghypertrophylong-actinganabolicrecovery

IGF-1 LR3

Long-acting IGF-1 analog for hypertrophy research

R 1 430
1mg vial
Extended half-life~20–30 hours versus minutes for native IGF-1 — a single daily injection sustains exposure.
Higher free fraction100× lower IGFBP affinity means more bioavailable peptide at lower doses.
Hypertrophy pathwayActivates PI3K / Akt / mTOR for protein synthesis and anti-atrophy signalling via FoxO suppression.
Satellite cell and proliferation effectsMAPK / ERK signalling drives myoblast proliferation in cell-culture and animal models.
IGF-1 LR3 (Long R3 IGF-1) is an 83-amino-acid synthetic analog of insulin-like growth factor 1 with a 13-residue N-terminal extension and an arginine substituted for glutamic acid at position 3. The Arg-3 substitution drops affinity for IGF binding proteins (IGFBPs) ~100-fold while preserving full agonism at the IGF-1 receptor, so more of the injected peptide is free to bind tissue. Half-life is ~20–30 hours versus minutes for native IGF-1. Downstream signalling runs through PI3K/Akt/mTOR (protein synthesis, anti-atrophy) and MAPK/ERK (proliferation).
Distributor
Elegant Slimming · Mokopane, Limpopo, South Africa
WhatsApp 076 547 8764 · Mon–Sat 9–5
Regulatory
This product has not been evaluated by the South African Health Products Regulatory Authority (SAHPRA).
For information purposes only — not intended to diagnose, treat, cure or prevent any disease.